Brian Cooley
« Dzokera kuChikwata
Mutevedzeri Mukuru weMutungamiri, Corporate Communications uye Lymphatic Drug Development BU
- 30+ makore echiitiko muiyo biopharmaceutical uye hupenyu sainzi indasitiri
- VaCooley vakabata zvinzvimbo zvakasiyana-siyana zvekutengesa, kushambadzira, uye hutungamiriri hwekutengeserana kumakambani ane rombo rakanaka 500 uye vakatungamira kubudirira kuunganidza mari nekutanga kuedza kumakambani ehunyanzvi hwekuchengetedza hutano.
- Vasati vajoinha Sorrento, Mr. Cooley vakatungamira kushambadzira kwepasi rose kuedza kwekutanga chigadzirwa nebasa reP&L paEli Lilly neCompany neGenentech munzvimbo dzechirwere dzinosanganisira Diabetes, Neurology, Immunology uye Rare Disease.
- Pamusoro pezvo, akatungamirawo zvakakosha BD, mu-rezinesi, uye kuedza kwekubatanidza pasi rose uye muUS Izvi zvaisanganisira akawanda mabhizinesi ekuwedzera madhiri kuEurope, Middle East neAfrica, uye chibvumirano chekubatana chemadhora mazana mana eMM ku-rezenisi, kusimudzira nekutengesa. yekutanga GLP-400 agonist
- Munguva pfupi yapfuura, Mr. Cooley vaiva CBO yeSofusa Business Unit paKimberly-Clark uye vakatungamirira kubudirira kwekutengesa nekubatanidza kuedza. Sorrento Therapeutics. Anoenderera mberi achitungamira chikamu cheLymphatic Drug Delivery system kuSorrento.
- BS